Introduction {#s02}
============

The dynamic organization of cells depends on protein-controlled membrane remodeling processes that divide and fuse membranes. Fusion of intracellular membranes is a key stage in secretion, protein and lipid trafficking, and in the maintenance of ER and mitochondrial networks, and defects in these fusion processes have been linked to mitochondrial, lysosomal storage ([@bib9]), and degenerative disorders ([@bib130]). Diverse enveloped viruses, including many human pathogens, infect cells by envelope--cell membrane fusion. Fusion between cells (referred to here as "cell fusion"), the focus of this review, is essential in fertilization and in development of tissues and organs such as skeletal muscles and placenta.

Fusion processes differ widely in the composition of the fusing membranes, biological context, and regulatory mechanisms. In some fusions, the proteins that mediate fusion (referred to as "fusion proteins" or "fusogens") have to be present on only one of the fusing membranes (unilateral mechanism). Other fusions require the same or different fusogens to be present on both membranes (bilateral homotypic vs. bilateral heterotypic mechanisms). However, in all fusion processes, the function of the fusion protein machinery is to drive the transition from the pre-fusion to post-fusion state by bringing lipid bilayers into immediate contact, catalyzing the formation of energy-intensive fusion intermediates, and opening a fusion pore ([@bib136]). Fusion itself involves local rupture of the continuity of each of the lipid bilayers and their rejoining. The mechanisms and pathways underlying cell fusion have been studied in both biological and protein-free lipid bilayers using different theoretical and experimental approaches yielding several important concepts ([@bib28]; [@bib96]). Before fusion, characteristic distances between opposing plasma membranes are controlled by specific cell--cell adhesion proteins and vary in range from 10 to a few tens of nanometers ([@bib83]; [@bib35]). Bringing membrane bilayers closer to each other requires displacement of membrane proteins toward the periphery of the fusion site and, at very close distances comparable with the thickness of the lipid monolayer (∼2 nm), overcoming very strong repulsive interactions related to hydration forces or thermal fluctuations ([@bib27]).

A strong bending of one or both membrane bilayers brings them into immediate contact (within a few nanometers) and facilitates a local disruption and rearrangement of the lipid monolayers ([@bib27]). The pathway of many fusion processes starts with hemifusion, a merger between contacting monolayers of the fusing bilayers that allows lipid mixing between the membranes ([@bib29]; [@bib27]). A subsequent merger of the distal monolayers generates a nascent fusion pore and allows content mixing ([Fig. 1](#fig1){ref-type="fig"}). While this fusion-through-hemifusion pathway was first described for fusion of protein-free bilayers formed from lipids that facilitate monolayer curvatures characteristic for either hemifusion intermediates or lipidic pores ([@bib29]), during biological fusion, proteins may serve as critical structural components of the early fusion intermediates. For instance, some studies suggest that Ca^2+^-triggered exocytosis involves formation of a proteinaceous fusion pore, the rim of which is entirely or partially lined by amino acid residues of transmembrane domains of SNARE proteins ([@bib25]). It has been also suggested that under some conditions, influenza virus hemagglutinin initiates fusion by puncturing one of the contacting membranes to form a leaky "rupture-insertion" structure, and this structure by a yet-unexplained mechanism facilitates hemifusion and opening of a fusion pore ([@bib54]). The place of these intermediates in the productive fusion pathway that yields expanding fusion pores remains to be clarified. The hypothesis that fusion starts with a channel-like proteinaceous pore can be substantiated by finding the mechanisms that drive its transition to a larger lipidic pore and ways to specifically block this transition. To verify that the rupture-insertion structure is not a branch-off the normal fusion pathway, leakage measurements will have to be accompanied by content mixing assays. In our opinion, striking similarities between lipid dependences and properties of the key intermediates in diverse biological membrane fusion processes and in fusion of protein-free lipid bilayers ([@bib27], [@bib28]) argue for similar pathways and suggest that proteins catalyze a fusion-through-hemifusion fusion pathway ([Fig. 1 B](#fig1){ref-type="fig"}) that is intrinsic for membrane bilayers and driven by membrane bilayer stresses.

![**Mechanisms of cell--cell fusion. (A)** The pathway of cell--cell fusion. Ready-to-fuse cells (1) recognize and closely appose each other (2) and undergo hemifusion (3), i.e., the merger of the outer monolayers of two membrane bilayers, allowing redistribution of the lipid markers between the cells (note that both distal monolayers of the membranes and cell contents remain distinct). Opening of a fusion pore in the hemifusion structure allows the mixing of the cytoplasmic contents (4), and pore expansion completes joining of two cells into one (5). While Myomaker/Myomerger, syncytins, and fusexins seem to be for now the only proteins necessary for specific fusion processes, they are most likely working with other players, some of which, especially for myoblasts, are already identified. Fusexins and syncytins mediate all the stages of the fusion process; in contrast, Myomaker is required for an early stage involving the transition to hemifusion, while Myomerger is required for a later stage between hemifusion and opening of fusion pores (see the main text). **(B)** Schematic representation of the lipid rearrangements during the events explained in A. LPC blocks hemifusion by inhibiting the bending of the contacting monolayers ([@bib27]). **(C)** Inset from A 2: Protein fusogens are necessary to overcome the energetic barriers of hemifusion and opening and expansion of the fusion pore. Examples display bilateral and homotypic fusions mediated by *C. elegans* EFF-1 (upper panel) and *Arabidopsis* HAP2 (middle panel) as well as a bilateral and heterotypic fusion between them (lower panel; [@bib167]).](JCB_201901017_Fig1){#fig1}

Up to a third of the cell nuclei in animals, from *Caenorhabditis elegans* to humans, are found in multinucleated cells formed by cell fusion (in *C. elegans* mostly in epithelia and in humans in skeletal muscle; [@bib124]). However, most cells remain mononucleated, emphasizing that cell fusion is tightly regulated. In this review we discuss different cell fusion processes and proteins suggested to mediate them, intercalating videos illustrating the dynamics of cell fusion in different systems.

Challenges in identifying and exploring cell--cell fusion {#s03}
=========================================================

Fusion processes mediated by viral and intracellular proteins are often triggered by calcium (exocytosis), acidification of endosomal compartments containing internalized virions (influenza virus), and/or virus interactions with receptors and fusion cofactors in host cells (human immunodeficiency virus \[HIV\] and Dengue virus). Such events are relatively fast (milliseconds to hours; reviewed in [@bib68]; [@bib122]). In contrast, complex and multistep differentiation processes that prepare cells for fusion in their biological context may take days, and the environmental cues that trigger the actual fusion events (seconds to minutes) are yet to be established.

How do we distinguish proteins involved in the actual fusion stage from proteins that only function at pre- and post-fusion stages? Identifying proteins as fusion proteins (fusogens) depends on diverse experimental approaches characterizing their fusogenic activities and structural characteristics. The gold standard is that a fusogen (or fusogenic complex) has to be (1) necessary for fusion, (2) present on the fusing membranes at the right time and place, and (3) sufficient to fuse membranes that normally do not fuse. Additionally, a tertiary structure similar to well-characterized fusogens is commonly used by many researchers for validation of new fusogens. Proteins that meet all these requirements are considered bona fide fusogens, and we suggest a scoring system based on gold standards for fusogens ([Table 1](#tbl1){ref-type="table"}). A decade ago, when a similar table was assembled, the best-characterized fusogens were viral and intracellular; the only well-characterized cell--cell fusogens were identified in the placenta of mammals (Syncytins \[Syns\]) and epithelia of nematodes (Fusion Family \[FF\]; [@bib116]). Recent studies have suggested new candidate proteins in fusion of gametes (Hapless 2 \[HAP2\]) and of muscle cells (Myomaker/Myomerger; [@bib59]; [@bib134]). Our discussion of different fusion processes and machineries will focus on recent mechanistic discoveries at the molecular, structural, and biochemical levels.

###### Examples of candidate fusogens

  **Protein**        **Family**                                **Organism**                         **Suggested fusion event**                       **Fusogenic score**[^a^](#ttbl1n2){ref-type="table-fn"}   **Essential for fusion (0--2)**   **Structural similarity to fusogens (0--2)**   **Expressed at the time and place of fusion (0--2)**   **Sufficiency (0--4)**[^b^](#ttbl1n3){ref-type="table-fn"}   **References**             
  ------------------ ----------------------------------------- ------------------------------------ ------------------------------------------------ --------------------------------------------------------- --------------------------------- ---------------------------------------------- ------------------------------------------------------ ------------------------------------------------------------ ---------------- ---- ---- ---------------------------------------------------------------
  HA                 Class I viral fusogens                    Influenza virus                      Viral infection                                  10                                                        \+                                \+                                             \+                                                     \+                                                           \+               \+   \+   Reviewed in [@bib76]
  p14                FAST proteins (Class IV viral fusogens)   Reptilian orthoreoviruses            Infected cells                                   10                                                        \+                                \+                                             \+                                                     \+                                                           \+               \+   \+   Reviewed in [@bib75]
  E1                 Fusexins (Class II viral fusogens)        Semliki Forest virus                 Viral infection                                  9.5                                                       \+                                \+                                             \+                                                     \+                                                           \+               \+   ±    Reviewed in [@bib76]
  vSNARES, tSNARES   SNAREs (endoplasmic fusogens)             Eukaryotes and Archaea               Intracellular vesicles                           9                                                         \+                                \+                                             \+                                                     \+                                                           \+               ND   \+   Reviewed in [@bib68]
  EFF-1              Fusexins (FF)                             *C. elegans;* Nematodes              Epithelia, vulva, pharynx, axons                 9                                                         \+                                \+                                             \+                                                     \+                                                           \+               \+   ND   [@bib103]; [@bib143]; [@bib125]; [@bib7]
  Syncytins          Class I viral fusogens                    Placental mammals                    Placenta, osteoclasts, myoblasts, cancer cells   9                                                         \+                                \+                                             \+                                                     \+                                                           \+               \+   ND   [@bib17]; [@bib99]; [@bib16]; [@bib5]; [@bib39]; [@bib152]
  Atlastins          Dynamin (endoplasmic fusogen)             Eukaryotes                           Endoplasmic reticulum                            8                                                         \+                                \+                                             \+                                                     \+                                                           ND               ND   \+   Reviewed in [@bib62]
  HAP2/GCS1          Fusexins (HAP2)                           *Arabidopsis*; plants                Fertilization (sperm)                            8                                                         \+                                \+                                             \+                                                     ND                                                           \+               \+   ND   [@bib105]; [@bib171]; [@bib167]
  AFF-1              Fusexins (FF)                             *C. elegans;* Nematodes              Epithelia, vulva, pharynx, dendrites             8                                                         \+                                ±                                              \+                                                     \+                                                           \+               \+   ND   [@bib135]; [@bib7]
  Myomaker           Multi-pass transmembrane protein          *Mus musculus*; Human                Myoblasts                                        6                                                         \+                                ND                                             \+                                                     \+                                                           \+               ND   ND   [@bib100]; [@bib13]; [@bib46]; [@bib129]; [@bib184]; [@bib85]
  Myomerger          Single-pass transmembrane protein                                                                                                                                                                                                                                                                                                                                                                                         
  HAP2/GCS1          Fusexins (HAP2)                           *T. thermophila*; Trypanosomes       Mating                                           6                                                         \+                                \+                                             \+                                                     ND                                                           ND               ND   ND   [@bib121]
  HAP2/GCS1          Fusexins (HAP2)                           *Chlamydomonas*; Algae               Fertilization (mt− cell)                         6                                                         \+                                \+                                             \+                                                     ND                                                           ND               ND   ND   [@bib91]; [@bib42]
  Bouncer            Ly6/uPAR                                  *Danio reri* and *Oryzias latipes*   Fertilization (egg)                              5                                                         \+                                −                                              \+                                                     \+                                                           ND               ND   ND   [@bib57]
  Izumo1             IgSF                                      *M. musculus*; Mammals               Fertilization (sperm)                            4                                                         \+                                −                                              \+                                                     −                                                            −                ND   ND   [@bib64], [@bib65], [@bib66]; [@bib24]
  Juno               Folate receptors                          *M. musculus*; Mammals               Fertilization (oocyte)                           4                                                         \+                                −                                              \+                                                     −                                                            −                ND   ND   [@bib15]; [@bib72]
  SPE-9              EGF repeats                               *C. elegans;* Nematodes              Fertilization (sperm)                            4                                                         \+                                ND                                             \+                                                     ND                                                           ND               ND   ND   [@bib149]
  Sns                IgSF                                      *Drosophila*                         FCM                                              4                                                         \+                                ND                                             \+                                                     −                                                            −                ND   ND   [@bib21]; [@bib145]
  Duf/Kirre          IgSF                                      *Drosophila*                         FC                                               4                                                         \+                                ND                                             \+                                                     −                                                            −                ND   ND   [@bib132]; [@bib145]
  Bindin             Bindins                                   *S. purpuratus*; Sea urchins         Fertilization (sperm)                            3                                                         ND                                ND                                             \+                                                     ND                                                           ND               ND   \+   [@bib166]; [@bib52]; [@bib165]
  PRM1               Tetraspanin integral protein              *S. cerevisiae*; Yeast               Mating                                           3                                                         ±                                 ND                                             \+                                                     −                                                            ND               ND   ND   [@bib56]; [@bib115]

The fusogenic score (0--10) was calculated using the following scoring system: + (requirement fulfilled) = max score, − (requirement not fulfilled) = 0 points, ND (not determined) = 0 points, and ± (requirement partially fulfilled) = half of max score.

The fusogenic score (0--10).

\(A\) Sufficient in situ (0--1). (B) Fuse heterologous cells (0--1). (C) Fuse pseudo-typed virus (0--1). (D) In vitro liposome fusion (0--1).

Gamete fusion {#s04}
=============

Sexual reproduction is widely distributed in the tree of life. In sexually reproducing organisms, permanent or transient cell--cell fusion is essential for genetic transfer (Video 1). Here we will focus on mechanisms of gamete fusion in eukaryotes.

Gamete fusion mediated by HAP2/Germ cell--specific 1 (GCS1) {#s05}
-----------------------------------------------------------

Recent years have brought about a breakthrough in the identification of proteins that fuse gametes. HAP2, also named GCS1, is a type I transmembrane protein that functions in late stages of gamete fusion in different species including protists ([@bib91]), flowering plants ([@bib105]; [@bib171]), and invertebrates (reviewed in [@bib59]). It is localized in at least one of the fusing membranes at the moment of fertilization and is required for fusion (i.e., necessary and present; [@bib105]; [@bib171]; [@bib91]). Recent evidence in the algae *Chlamydomonas reinhardtii* ([@bib42]; [@bib44]), the flowering plant *Arabidopsis thaliana* ([@bib167]; [@bib43]), and the ciliate *Tetrahymena thermophila* ([@bib121]) revealed that HAP2 has similarities with the eukaryotic somatic fusogen epithelial fusion failure-1 (EFF-1) and class II viral fusogens. *Arabidopsis* HAP2 expression in heterologous mammalian cells results in their hemifusion and cytoplasmic content mixing ([@bib167]). Moreover, vesicular stomatitis virus with a deletion of G glycoprotein--HAP2 virus expressing HAP2 instead of the viral G glycoprotein effectively enters cells. These studies of the HAP2 sufficiency for fusion indicate that HAP2 is indeed a bona fide fusogen ([@bib167]; [Table 1](#tbl1){ref-type="table"}). Yet it remains unclear whether HAP2 from different species use unilateral, bilateral, or hybrid mechanisms in vivo and in cell-free systems ([Table 2](#tbl2){ref-type="table"}). *Arabidopsis* HAP2 induces fusion only when it is present in both of the opposing membranes, suggesting a bilateral mechanism of action, similar to the related somatic fusogen EFF-1 ([@bib167]; [Fig. 1 C](#fig1){ref-type="fig"}). On the other hand, *Chlamydomonas* HAP2 is required only in the minus gamete ([@bib91]), and although some HAP2 expression was detected in *Arabidopsis* ovules ([@bib19]), the deletion of this gene produces male-specific sterility ([@bib69]; [@bib171]). This implies that in vivo*,* sperm HAP2 acts in trans with other unknown egg proteins or uses a unilateral mechanism ([@bib167]). Perhaps, unilateral fusion requires HAP2 and another sperm protein, and expression of HAP2 alone in a heterologous system is insufficient for its unilateral action. In the slime mold *Dictyostelium discoideum*, there are three mating types and at least two different genes encoding HAP2/GCS1 proteins. Genetic analyses of the mating-type specific gamete fusion in *D. discoideum* suggest that the fusogens form complexes in trans supporting a bilateral mechanism between Type I and II gametes ([@bib114]). The structural similarities between HAP2 proteins and the class II viral fusogens suggest that they share common functional features. Class II viral fusogens possess an amphiphilic loop at the tip of domain DII that inserts into and destabilizes the host cell membrane (reviewed in [@bib122]). Structural and biochemical analyses suggest that HAP2 proteins of *Chlamydomonas, Arabidopsis,* and trypanosomes interact with membranes through similar regions (composed of loops and/or α-helixes) containing hydrophobic amino acids ([@bib42], [@bib43]; [@bib44]). However, this ability to interact with membranes does not imply unilateral action: other cellular fusogens that use bilateral mechanisms have domains that directly interact with membranes, yet still join trans-complexes which mediate fusion (e.g., atlastins and synaptotagmins; [Table 2](#tbl2){ref-type="table"}; [@bib26]; [@bib41]; [@bib92]).

###### Mechanism of action for some of the best candidate fusogens

  **Protein**        **Organism**                     **Homotypic/Heterotypic**   **Bilateral/Unilateral**   **Dependent on regulators**            **Triggers**                References
  ------------------ -------------------------------- --------------------------- -------------------------- -------------------------------------- --------------------------- ---------------------------------------------------------------
  HA                 Influenza virus                  Heterotypic                 Unilateral                 Receptors                              Low pH                      Reviewed in [@bib76]
  p14                Reptilian orthoreoviruses        Heterotypic                 Unilateral                 Cholesterol, calcium                   ND                          Reviewed in [@bib75]
  E1                 Semliki Forest virus             Heterotypic                 Unilateral                 Cholesterol                            Low pH                      Reviewed in [@bib76]
  vSNARES, tSNARES   Eukaryotes and Archaea           Heterotypic                 Bilateral                  Synaptotagmin, complexin, and others   Docking                     Reviewed in [@bib68]
  EFF-1              *C. elegans*; Nematodes          Hetero/Homo                 Bilateral                  Dynamin, vATPase, PS                   ND                          [@bib103]; [@bib143]; [@bib125]; [@bib7]; [@bib109]
  Atlastins          Eukaryotes                       Homotypic                   Bilateral                  Dimerization                           GTP hydrolysis (?)          Reviewed in [@bib62]
  Syncytins          Placental mammals                Heterotypic                 Unilateral                 Receptor, Anxs, PS                     Externalization of PS (?)   [@bib17]; [@bib99]; [@bib16]; [@bib39]; [@bib152]
  HAP2/GCS1          *Arabidopsis*; plants            Heterotypic                 Uni/Bi                     ND                                     ND                          [@bib167]
  AFF-1              *C. elegans*; Nematodes          Hetero/Homo                 Bilateral                  ND                                     ND                          [@bib135]; [@bib7]
  Myomaker           *M. musculus*; Human             Homotypic                   Bilateral                  Anxs, PS binding proteins              PS exposure (?)             [@bib100]; [@bib13]; [@bib46]; [@bib129]; [@bib184]; [@bib85]
  Myomerger          Heterotypic                      Unilateral                                                                                                                
  HAP2/GCS1          *T. thermophila*; Trypanosomes   Hetero/Homo                 Uni/Bi                     ND                                     ND                          [@bib121]
  HAP2/GCS1          *Chlamydomonas*; Algae           Heterotypic                 Unilateral                 ND                                     ND                          [@bib42]

ND, not determined; ?, not confirmed.

Fertilization in organisms lacking HAP2/GCS1 {#s06}
--------------------------------------------

Despite the wide distribution of HAP2 among eukaryotes, some lineages like nematodes, fungi, and vertebrates lack any close HAP2 orthologue ([@bib156]; [@bib167]; [@bib43]). Although the fusogens involved in gamete fusion in these HAP2-lacking species are still unknown, several proteins have been shown to be relevant to this process, especially those related to the early recognition between gametes ([Table 1](#tbl1){ref-type="table"}). Examples include PRM1 from yeast ([@bib56]), the SPE-9 class from *C. elegans* (reviewed in [@bib110]; Video 1), and Bindin from sea urchins ([@bib166]).

In mammals, certain proteins in both male and female gametes are necessary for gamete fusion, but none have been determined sufficient for membrane fusion ([@bib178]). Izumo1, an immunoglobulin superfamily member, localizes to the sperm acrosomal membrane ([@bib64]). Following acrosome exocytosis, Izumo1 migrates to the equatorial segment of the sperm ([@bib137]), the site of fusion with the egg. Sperm of *Izumo1* knockout mice fails to fuse, leading to male infertility ([@bib64]). Females lacking the GPI-anchored Izumo1 Receptor (Juno) are also infertile due to defects in gamete fusion ([@bib15]). Shortly after sperm--egg fusion, Juno is shed from the egg membrane, preventing further sperm binding, thus contributing to the block of polyspermy ([@bib15]). Juno and Izumo1 are conserved among mammals, including humans, where antibodies against Izumo1 and mutations in Juno are associated with female infertility ([@bib31]; [@bib183]). The interaction between these adhesion partners is bilateral in humans ([@bib8]; [@bib112]) and appears to be species specific ([@bib14]). Heterologous cells expressing Juno or Izumo1 are able to adhere to sperm or eggs, respectively; however, this interaction is insufficient to mediate cell--cell fusion, suggesting the existence of additional molecular players ([@bib65], [@bib66]; [@bib24]; [@bib72]). In addition to Izumo1-Juno interactions, the egg-specific tetraspanin CD9 is necessary for gamete fusion ([@bib70]; [@bib86]; [@bib101]) but its role seems to be related to the organization of microvilli ([@bib133]). In sperm, the immunoglobulin-like protein SPACA6, is essential for gamete fusion ([@bib94]). Recently, the egg GPI-anchored protein Bouncer was shown to be necessary during Zebrafish gamete fusion ([@bib57]). Bouncer mediates fertilization in a species-specific manner, and its heterologous expression in eggs of a different fish (Medaka) is sufficient to induce fusion with Zebrafish sperm ([@bib57]). Bouncer has a mammalian orthologue (SPACA4) that is sperm specific; more studies regarding the fusogenic role of both Bouncer and SPACA4 are required ([Table 1](#tbl1){ref-type="table"}).

At present, gamete fusogens in organisms lacking HAP2-like proteins remain to be identified. During evolution, HAP2 orthologues may have diverged so rapidly that bioinformatic tools are unable to detect distant phylogenetic relationships. In this sense, these hypothetical divergent proteins may conserve structural similarities to HAP2 or to other fusexins (e.g., EFF-1 and anchor cell fusion failure-1 \[AFF-1\] from nematodes; [Table 1](#tbl1){ref-type="table"}; [@bib42]; [@bib121]; [@bib167]). Another possibility is that HAP2 genes were replaced by different fusogens of viral origin acquired by horizontal gene transfer during evolution. Alternatively, these phylogenetic groups may depend on new eukaryotic fusogens unrelated to HAP2 or viral fusogens ([@bib37]).

Somatic cell fusion and organ formation {#s07}
=======================================

In the next sections, we discuss cell--cell fusion in different tissues and organs and focus on fusion processes during the development of muscles, placenta, bones, stem cells, and synergid-endoplasm. We also review cell fusion in disease (cancer and viral infections) and then analyze the detailed map of cell--cell fusions in *C. elegans*, describing how fusion proteins sculpt cells in the epidermal, digestive, reproductive, and nervous systems.

Myoblast fusion {#s08}
---------------

Skeletal muscles are composed of bundles of elongated multinucleated myofibers that form by fusion of mononucleated myoblasts. Myoblast fusion is necessary for myofiber maintenance, growth, and regeneration ([@bib134]).

Genetic work in *Drosophila melanogaster* embryos led to a model of myoblast fusion in which two distinct populations of myoblasts differentiate and cooperate during fiber formation. The founder cells (FCs) seed the formation of specific muscle fibers by fusion with fusion-competent myoblasts (FCMs; [@bib12]; Video 2). More recent reports revealed a ring of FCM/FC adhesion molecules encircling the F-actin--enriched focus ([@bib74]). These podosome-like structures formed by plasma membranes of FCMs insert into FCs ([@bib139]). The FCs mount a Myosin II-- and spectrin-mediated response that controls the diameter and shape of the protrusions from the FCMs to promote fusion ([@bib78]; [@bib38]). In contrast to the mechanism of myoblast fusion at the tip of the protrusion suggested for *Drosophila* embryo, later in the development of indirect flight muscles, multiple fusion pores are formed in extended (∼4 µm) and tight (inter-cellular distance of ∼20 nm) membrane contacts ([@bib35]). Studies in different organisms have identified molecular components involved in the generation of multinucleated muscle cells including actin, adhesion, and endocytic machineries; tetraspanin CD9, ferlins, JAM-B, and JAM-C receptors; and immunoglobulin domain--containing membrane receptors such as Kirrel in Zebrafish embryo ([@bib162]; [@bib157]; [@bib126]; [@bib128]; [@bib84]; [@bib78]; [@bib138]; [@bib134]).

Formation of muscle fibers is inhibited by the hemifusion-inhibiting lipid lysophosphatidylcholine (LPC), promoted by the phosphoinositide PI(4,5)P2, and associated with cell surface exposure of phosphatidylserine (PS; [@bib168]; [@bib60]; [@bib84]; [@bib20]; [@bib177]). Myoblast fusion is also dependent on PS-binding proteins annexins (Anxs), stabilins, and the PS-exposure--mediating protein TMEM16E ([@bib84]; [@bib77]; [@bib55]; [@bib177]). Two muscle-specific proteins, Myomaker (Tmem8c) and Myomerger (Gm7325/Myomixer/Minion), have been shown to be essential for vertebrate myoblast fusion ([@bib100]; [@bib13]; [@bib46]; [@bib129]; [@bib184]; [@bib85]). Myomaker has seven transmembrane domains, and Myomerger is an 84--amino acid integral membrane protein with a C-terminal ectodomain ([@bib100]; [@bib85]). Expressing both Myomaker and Myomerger in fibroblasts, but not separately, is sufficient to induce cell--cell fusion. In contrast to Myomaker, which is able to support fusion only if expressed in both fusing cells, Myomerger is required in only one of the cells ([Table 2](#tbl2){ref-type="table"}).

To identify the proteins and lipids directly involved in myoblast fusion, ready-to-fuse murine myoblasts were accumulated in the presence of LPC without blocking pre-fusion differentiation, followed by LPC removal to observe robust and synchronized fusion ([@bib84]). Specific treatments such as antibodies and inhibitors applied during LPC removal focused the analysis of the contributions of candidate proteins and lipids on the cell fusion stage of myogenesis ([@bib84], [@bib85]). This approach combined with application of three complementary fusion assays (syncytium formation, lipid mixing, and content mixing) allowed researchers to distinguish proteins involved only in pre-fusion stages of myogenesis from proteins involved in hemifusion or in pore formation and expansion ([Fig. 1](#fig1){ref-type="fig"}). It was shown that cell-surface AnxA1 and AnxA5 ([@bib84]) and Myomaker ([@bib46]; [@bib85]) function at the hemifusion stage of myoblast fusion. The transition from myoblast hemifusion to syncytium formation (multinucleation) depends on cell metabolism, dynamin 2 activity, and phosphoinositide PI(4,5)P2 concentration ([@bib84]), as well as the cell-surface Myomerger ([@bib85]). While fusion of Myomerger-deficient myoblasts stall at hemifusion, Myomaker-deficient myoblasts do not form even early hemifusion intermediates, confirming that Myomaker functions at or upstream of hemifusion and that Myomerger probably drives pore formation ([@bib85]). Myomaker does not need Myomerger to mediate hemifusion, and Myomerger does not need Myomaker to complete the fusion once hemifusion is reached, demonstrating independent and distinct functions of these proteins at different fusion steps ([Fig. 1 A](#fig1){ref-type="fig"}). The specific roles of Myomaker in hemifusion and Myomerger in fusion pore opening, as well as the mechanisms by which muscle microenvironment trigger and coordinate fusion-related proteins and lipids in distinct stages of the fusion pathway, remain to be clarified ([@bib138]; [@bib134]; [Table 2](#tbl2){ref-type="table"}).

Placental trophoblast fusion {#s09}
----------------------------

Fusion of villous cytotrophoblasts throughout pregnancy generates syncytiotrophoblast, a giant cell with more than 10 billion nuclei and an ∼10-m^2^ surface area that serves as the main fetomaternal barrier ([@bib127]; [@bib18]). This cell fusion depends on the endogenous retroviral proteins, namely, Syn1 and Syn2 in primates, and SynA and SynB in rodents. Interactions of Syn1 and Syn2 with their receptors, ubiquitous neutral amino acid transporters ASCT1 and ASCT2, trigger this fusogenic restructuring ([@bib127]; reviewed in [@bib2]). Syncytin-mediated trophoblast fusion is accompanied by formation of podosome-like plasma membrane protrusions ([@bib173]) and PS exposure ([@bib127]), and involves AnxA5 ([@bib33]). Specific contributions of different syncytins and the mechanisms that ensure the appropriate timing and specificity of this fusion process (trophoblasts fuse only with each other and the syncytiotrophoblast) remain to be determined (see Movie S 3 in [@bib173]).

Osteoclast precursor fusion {#s10}
---------------------------

Bone remodeling during development and in bone maintenance depends on the balance between bone formation by osteoblasts and bone resorption by osteoclasts. The latter are generated by fusion of osteoclast precursors (preosteoclasts) derived from monocyte/macrophage lineage after macrophage colony stimulating factor and RANKL stimulation ([@bib88]). Larger osteoclasts with multiple nuclei resorb bones better than mononucleated osteoclasts ([@bib82]), and thus changes in fusion efficiency are expected to disrupt normal bone remodeling. As with myoblasts and trophoblasts, fusion of preosteoclasts involves actin-enriched podosome-like protrusions ([@bib113]) and distinct populations of precursor cells that differ in protein expression and in fusion competence ([@bib88]; and see Movie 1 therein). Several proteins, including CD9 ([@bib67]), a dendritic cell specific transmembrane protein ([@bib179]), the endocytotic machinery including dynamin 2, clathrin, and AP-2 ([@bib146]; [@bib169]), and Syn1 ([@bib152]), are involved in osteoclast formation and may function in fusion itself ([Table 1](#tbl1){ref-type="table"}).

Recent analysis using a fusion synchronization approach has established that dendritic cell specific transmembrane protein and Syn1 are involved in the human preosteoclast hemifusion ([@bib170]). In addition, this fusion stage depends on TMEM16F-mediated exposure of PS, AnxA5 (PS-binding protein), and S100A4 (Anx-binding protein; [Table 2](#tbl2){ref-type="table"}). Again bearing similarity to myoblasts, generation of multinucleated osteoclasts depends on cell metabolism and dynamin 2 ([@bib146]; [@bib169]) at the stage of the expansion of local membrane connections ([@bib169]). These findings indicate that preosteoclast fusion is controlled by a complex multiprotein fusion machinery, and future studies will likely expand the list of the protein components involved and clarify their role.

Stem cell fusion and fusion in liver and eye {#s11}
--------------------------------------------

While the role of cell fusion in myogenesis, osteoclastogenesis, placentogenesis, and fertilization is well established, there are additional biological processes that have been hypothesized to depend on fusion. In analogy to fusion of differentiating skeletal muscle stem cells (satellite cells) that plays a key role in muscle regeneration, fusion has been suggested to be involved in the repair and regeneration of other tissues mediated by adult and embryonic stem cells ([@bib120]). Bone marrow adult stem cells (BMSCs) differentiate into many lineages including hepatocytes, neurons, and cardiomyocytes ([@bib163]; [@bib53]). Through bloodstream circulation, BMSCs come into contact with different tissues, allowing these cells to be involved in the regeneration of different types of tissues. Do BMSCs facilitate the regeneration by fusion to the resident cells? This hypothesis has been substantiated by reports that bone marrow--derived cells can fuse with certain types of cells including Purkinje neurons, cardiomyocytes, and hepatocytes (reviewed in [@bib120]). In addition to a possible role of BMSC fusion, tissue regeneration can also involve fusion between mesenchymal and embryonic stem cells ([@bib153]). In contrast to the very efficient fusion of the satellite cells, BMSC fusion and mesenchymal stem cell fusion events are very rare (generally under 2% of cells in the population and as low as ∼1 in 500,000 cells \[[@bib163]\]). This hinders unambiguous analysis of their potential role and mechanism in tissue regeneration, and the significance of their in vivo regeneration of tissues other than skeletal muscle is still lacking solid evidence ([@bib71]; [@bib93]; [@bib120]).

Cell fusion has been also discussed as a possible mechanism of formation of polyploid liver cells, but while hepatocytes can fuse in vitro, the physiological relevance in vivo remains controversial ([@bib93]). In another poorly understood example of a potentially important cell fusion processes, terminal differentiation of fiber cells in the vertebrate lens results in their partial fusion that generates the lens syncytia in which fusion pores connecting constituent cells facilitate intercellular diffusion but do not expand ([@bib144]).

Fertilization-independent cell fusion between the persistent synergid and endosperm {#s12}
-----------------------------------------------------------------------------------

In flowering plants, a somatic cell--cell fusion that occurs after double fertilization has been shown to eliminate the persistent synergid signaling cell in a process alternative to apoptosis that is mechanistically independent of sexual cell fusions ([@bib97]; reviewed in [@bib98]). The persistent synergid is necessary for pollen attraction. During plant double fertilization, the pollen tube releases two sperm into the ovule. One sperm fuses with the egg while the other fuses to the central cell to form the endosperm. A few hours later, the endosperm fuses with the persistent synergid cell (see Movie S1 in [@bib97]). After the fusion, the nucleus of the persistent synergid cell becomes disorganized while the endosperm nucleus divides. While the gamete fusion events are HAP2-mediated, and require actin polymerization and protein secretion, the somatic synergid--endosperm fusion is independent of HAP2 and filamentous actin, and dependent on cyclin-dependent kinases ([@bib106]).

Cell fusion in disease {#s13}
======================

Disrupted or unbalanced cell fusion in developmental processes is linked to human diseases. Defects in sperm--egg fusion lead to male infertility ([@bib107]). Impediments in myoblast fusion can be perinatally lethal in mice and have been associated with some human myopathies ([@bib36]; [@bib134]). Syncytin-mediated trophoblast fusion is critical for normal pregnancy, and defects in this fusion have been linked to preeclampsia ([@bib18]). Unbalanced bone remodeling due to excessive and insufficient osteoclast fusion can lead to osteoporosis and osteopetrosis ([@bib179]). Fusion between cells that do not normally fuse has been also linked to diseases including cancer and viral infections, discussed in the following sections.

Cell fusion in cancer {#s14}
---------------------

In the early 1900s, Otto Aichel suggested that leukocyte-like characteristics of metastatic cancer cells that facilitate their migration through the blood are acquired by their fusion with white blood cells ([@bib3]). Since then, many studies have substantiated the hypothesis that fusion among cancer cells and between cancer cells and nonmalignant cells can contribute to initiation and progression of cancer and, specifically, aneuploidy, drug resistance, and metastatic potential characteristic of malignant cells. Indeed, cancer cells do fuse with each other ([@bib111]; [@bib164]). Different cancer cells also spontaneously fuse with nonmalignant cells. For instance, prostate cancer cells fuse with stromal and skeletal muscle cells, and breast cancer cells fuse with normal mammary gland cells and with endothelial cells ([@bib73]). Hybrid cells generated by cancer cell/dendritic cell fusion can actually induce an anti-tumor immune response and can potentially be used as a treatment for colorectal and renal cancer ([@bib79]). However, in most cases, such hybrid cells have cancer stem cell properties with elevated metastatic potential, proliferation rate, and drug resistance (reviewed in [@bib10]; [@bib111]; [@bib47]; [@bib174]). Most recently, it has been shown that fusion between cancer cells and leukocytes increases tumor heterogeneity, and the number of the hybrid cells in blood of human patients correlates with cancer stage ([@bib47]; Video 3). The hypothesis that drastic changes in the properties of the cells upon their fusion can initiate and promote malignancy is further supported by the elegant demonstration that fusion between nontransformed, cytogenetically stable epithelial cells brought about by a chemical fusogen initiates chromosomal instability, cell transformation, and malignancy ([@bib186]).

In a recent study aimed at modeling the effects of muscle cells surrounding the prostate gland on prostate cancer cells, coculturing prostate cancer cells with primary skeletal or smooth muscle cells resulted in cancer cell fusion ([@bib164]). Fusion between cancer cells was found to expand the subpopulations of the cells with cancer stem cell features, suggesting that this fusion reaction promotes cancer progression. This novel system obtains a relatively high efficiency of cancer cell fusion with 10--20% of cell nuclei located in fusion-generated multinucleated cells, facilitating the analysis of the underlying mechanisms ([@bib164]). Cancer cell fusion in prostate cancer/muscle cell cocultures involves a placental fusogen Syn1 (implicated in cancer cell fusion \[[@bib111]\]) and AnxA5 ([@bib164]). Fusion is associated with up-regulation of these proteins and is inhibited by blocking their expression. Human prostate cancer cells have higher levels of Syn1 and AnxA5 expression than nonmalignant tissues. The case for the direct involvement in cancer cell fusion is especially strong for Syn1 as blocking fusogenic refolding of Syn1 with a peptide inhibitor abolishes fusion ([@bib164]). Interestingly, ASCT2, a Syn1 receptor, also has a role in cancer cell fusion, as evidenced by the finding that knocking down ASCT2 or Syn1 inhibits fusion between breast cancer cells and endothelial cells ([@bib16]). Knocking down ASCT2 also inhibits cell proliferation and growth of different tumors ([@bib172]).

With regard to the tumor microenvironment, interactions with muscle apparently trigger fusion of prostate cancer cells by raising concentrations of anti-inflammatory interleukins 4 and 13 in the medium ([@bib164]). Cancer cell fusion and fusion-dependent disease progression can be also triggered by inflammation, hypoxia, and oxidative stress, and have been associated with apoptotic pathways ([@bib104]). All these fusion-triggering processes have been linked to PS externalization, and many different cancer cells have an unusually high cell surface concentration of PS ([@bib140]). It remains to be clarified whether cancer cell fusion also depends on cell surface PS and at what stage. Better understanding of the mechanisms and steps of cancer cell fusion their role in cancer initiation and progression will hopefully help in development of new diagnostic tools and treatment options for the disease.

Cell fusion in viral infection {#s15}
------------------------------

In addition to virus--cell membrane fusion, a key stage in enveloped virus entry, some viruses are thought to use cell--cell fusion to spread infection between contacting cells. Cells infected with nonenveloped viruses such as baboon reovirus express fusion-associated small-transmembrane (FAST) proteins. FAST proteins facilitate virus spread between the cells by inducing cell fusion between infected and noninfected cells ([@bib30]; [Table 1](#tbl1){ref-type="table"}). T lymphocytes infected with HIV also express viral fusogen (HIV Env) and have been reported to form syncytia in lymph nodes of HIV patients and HIV infected humanized mice as well as in cell culture systems (reviewed in [@bib161]; [@bib32]). While these Env-mediated syncytia have been suggested to significantly contribute to HIV spread ([@bib161]), their role in the replication and pathogenesis of HIV-1 in vivo, and, more generally, the role of cell--cell fusion in different viral infections, still await additional analysis ([@bib32]).

Cell fusion sculpts tissues in *C. elegans* {#s16}
===========================================

The complete anatomy of *C. elegans* is known at EM resolution ([@bib176]), and this is the only known organism with an invariant cell lineage ([@bib159]), revealing that one third of all the somatic cells that are born as mononucleated cells fuse during development to become multinucleated ([@bib124]). The timing and locations of the somatic cell--cell fusions during morphogenesis of the embryonic epidermis are fully described (Video 4; [@bib124]; [@bib102]; [@bib34]; [@bib48]). During postembryonic (larval) development, additional cells merge with the major embryonic syncytium hyp7 forming the largest worm cell, containing 139 nuclei in the adult hermaphrodite ([@bib124]; [@bib182]). Additional multinucleate cells form in the epidermis and during organogenesis of the vulva, uterus, and hymen in the reproductive system ([@bib141]; [@bib80]; [@bib175]). In the digestive system, fusions occur in epithelial and myoepithelial cells of the pharynx and in different glands ([@bib143]). All these cell fusions are highly regulated at the transcriptional, translational, and posttranslational levels to ensure only correct partners fuse in spatial and temporal settings ([@bib142]; [@bib95]; [@bib135]; [@bib4]; [@bib22]). Precise combinations of signaling pathways including Notch, Wnt, and growth factors control each cell fusion event ([@bib23]; [@bib131]) in unison with microRNAs and heterochronic genes that temporally regulate the merger of cells and intracellular trafficking of fusogens and actin cytoskeleton which tightly control the correct localization and activity of the fusion machinery itself ([@bib148]; [@bib150]; [@bib185]).

EFF-1 and AFF-1 merge cells to sculpt epithelia and tubular organs {#s17}
------------------------------------------------------------------

Genetic screens in *C. elegans* identified two genes essential for developmental cell fusion events (reviewed in [@bib59]). Mutations in *eff-1* result in failure in most fusion events in the epidermis, reproductive, and digestive systems ([@bib103]). It is essential to define the shape of the epidermis, vulva, pharynx, and uterus. Loss of function of EFF-1 also results in abnormal cell fates and defective migration of unfused cells, and lower fertility (reviewed in [@bib123]; [@bib147]). EFF-1 is a type I membrane glycoprotein with primary sequence similarity to proteins in arthropods, ctenophores, some protists, and chordates (reviewed in [@bib6]), and its crystal structure reveals similarity to viral class II glycoproteins ([@bib119]). The second gene identified was named *aff-1*. It is a paralog of *eff-1* and is essential for cell fusions in the formation of the hymen, vulva, epidermis, and pharyngeal muscles ([@bib135]).

Genetic mosaic analysis at single-cell resolution in *C. elegans,* ectopic expression in insect cells, and analyses of cell fusion dynamics showed that EFF-1 is required in both fusing cells ([@bib143]; [@bib34]; [@bib125]; [@bib48]; [@bib180]). AFF-1 is also required in both fusing cells in worms, insect, and mammalian cells ([@bib135]; [@bib7]). EFF-1::GFP is rapidly endocytosed via dynamin-dependent receptor-mediated endocytosis and mostly localized in RAB-5--positive early endosomes. Failure to endocytose EFF-1 results in excess fusion and lethality ([@bib151]; Video 4). Independent support for the bilateral mechanism for EFF-1 and AFF-1 comes from fusion between pseudotyped vesicular stomatitis virus with a deletion of G glycoprotein--AFF-1 to cells ([@bib7]; [@bib45]). Even more remarkable, EFF-1 and HAP-2 can similarly interact in trans in such heterologous systems ([@bib167]; [Fig. 1 C](#fig1){ref-type="fig"}).

Although EFF-1 and AFF-1 are required in both fusing membranes in vivo (*C. elegans*) and in simpler systems (reviewed in [@bib122]), these fusogens may possess some supplementary unilateral activity via partial insertion of amphipathic domains, as noted for HAP2, only presumably much weaker ([@bib91]; [@bib42], [@bib43]). Moreover, EFF-1/AFF-1--mediated fusions apparently involve lateral cooperation in cis between fusogens ([@bib7]). This has also been shown for intracellular fusogenic complexes such as synaptotagmins, SNAREs, and atlastins ([@bib40]; [@bib58]; [@bib90]). The solved structures of EFF-1 and HAP2 provide a framework to help determine the mechanisms of action of these exoplasmic fusogens (fusexins; [Table 1](#tbl1){ref-type="table"}), and their ability to act in a heterotypic way demonstrates mechanistic conservation of action even between plants and animals ([Fig. 1 C](#fig1){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}).

Neuronal fusion {#s18}
---------------

Neuronal fusion was documented in invertebrates more than 50 yr ago ([@bib61]), and in the vertebrate peripheral nervous system (reviewed in [@bib51]). A system to cut axons using laser microsurgery (axotomy) was implemented in *C. elegans* ([@bib181]) and was used in a breakthrough experiment which determined that EFF-1 fuses cut axons in the PLM mechanosensory neuron ([@bib50]). EFF-1 directly mediates the reconnection process, and RAB-5--mediated endocytosis of EFF-1 controls the axonal fusion remodeling ([@bib89]). Based on rescue experiments, EFF-1 acts cell-autonomously in the PLM neuron during the axonal auto-fusion process ([Fig. 2](#fig2){ref-type="fig"}), and EFF-1::GFP localizes to the regenerating growth cone ([@bib109]). The reconnection by fusion of the severed PLM axons enables a recovery of the neuronal function of touch sensitivity, and intra-axonal vesicular transport is also restored (Video 5). PS exposure on the axonal outer membrane correlates with axonal fusion and increases with age, although auto-fusion capability itself declines with age. The microRNA *let-7* also inhibits the ability to recover functionality by EFF-1--mediated auto-fusion ([@bib1]; [@bib11]). Similar to its role in muscle fusion, PS is exposed and binds to secreted transthyretin (TTR-52) following axotomy. Axonal regeneration depends on, among others, NRF-5 (secreted lipid binding protein) and various components of the phagocytosis pathway (e.g., the engulfment receptor CED-1, CED-6 \[Engulfment Adaptor PTB Domain, GULP1\], and CED-7 \[ABC transporter\]; [@bib109]). The mechanisms underlying axonal repair by self-fusion following experimental injury in *C. elegans* have potential future applications in neurodegeneration and repair of neuronal injuries in vertebrates ([@bib50]; [@bib108]). In summary, EFF-1--mediated auto-fusion is highly regulated and plays a vital role in recovery of injured axons both structurally and functionally.

![**Alternative functions for cell--cell fusogens.** Membrane remodeling activity of EFF-1 and AFF-1 proteins is not limited to mediating cell--cell fusion events. Auto-fusion: a single cell fuses with itself to form donut-shaped cells that can stack and elongate to form tubes, or alternatively join a severed process, as in neuronal regeneration. Extracellular vesicle fusion: AFF-1 proteins can mediate the fusion between a vesicular carrier and the cell. Phagocytosis (EFF-1--mediated) and endocytosis (AFF-1--mediated): Fission events occur to seal the fission pore of the forming intracellular vesicle. Note that while endoplasmic fusogens (e.g., SNAREs and atlastins) act from the cytoplasmic space (light blue areas), EFF-1 and AFF-1 cell--cell fusogens induce fusion from the extracellular space (exoplasmic fusogens in white areas).](JCB_201901017_Fig2){#fig2}

EFF-1 has also been shown to control morphogenesis and maintenance of the stereotypic and complex dendritic trees of the PVD neuron ([@bib117]). EFF-1 can fuse and "prune" dendrites to model them during larval development, through adulthood and in response to laser microsurgery (dendrotomy; reviewed in [@bib154]). In contrast with the PLM axon, cut dendrites can auto-fuse in a process that requires AFF-1 noncell autonomously ([@bib117], [@bib118]). Dendrotomy induces production of AFF-1--containing extracellular vesicles derived from epidermal seam cells. A model was proposed in which AFF-1 proteins on extracellular vesicles fuse the dendrites and repair the lesion remodeling the dendritic trees from the outside ([@bib118]; [Fig. 2](#fig2){ref-type="fig"}). Another extrinsic function for EFF-1 in the sculpting of PVD dendritic trees is based on the epidermal localization of SAX-7(L1CAM) Ig domain protein ([@bib187]) and was recently reviewed ([@bib63]). Reduction in EFF-1 activity resulted in sprouting of dendrites, increasing the probability of repair by fusion ([@bib118]). Similar to axonal repair, dendritic regeneration is impaired in older adults, but can be rescued by ectopic expression of AFF-1 or through mutations in DAF-2 (Insulin growth factor-1 receptor), which is related to increased lifespan ([@bib81]). In summary, age-dependent remodeling of arborized dendrites is dependent on fusogens through auto-fusion and extracellular vesicles.

Other functions of cell--cell fusogens in auto-fusion, endocytosis, and phagocytosis {#s19}
====================================================================================

Some cell--cell fusogens also seem to play roles in other fusion processes. In different organisms, there are examples of a single cell fusing different parts of its own membrane to generate single-cell donuts (reviewed in [@bib160]). In *C. elegans*, EFF-1 and AFF-1 independently mediate auto-fusion of cells that wrap and form donuts that connect to construct tubes in the excretory and digestive systems ([@bib131]; [@bib158]; [Fig. 2](#fig2){ref-type="fig"}). The formation of small capillaries in vertebrates also uses auto-fusion strategies during vascular pruning ([@bib87]). Thus, auto-fusion can be a universal strategy to sculpt seamless donuts and small-scale tube structures ([@bib154]).

Another novel function for AFF-1 during excretory duct elongation in *C. elegans* was recently uncovered ([@bib155]). Using inducible AFF-1 degradation, it was shown how AFF-1 is necessary for auto-fusion of a seamless donut as previously discussed ([@bib158]), but its subsequent elongation to form a tube is independent of its early function ([@bib155]). During auto-fusion, AFF-1::mCherry localizes to apical junctions, while during subsequent tube cell elongation, it localizes mostly to basal membranes. During endocytosis, AFF-1 localizes at the necks of endocytic invaginations ([Fig. 2](#fig2){ref-type="fig"}). *aff-1* mutants in *C. elegans* have a shortened excretory duct cell, with accumulated membrane inclusions and vesicles suggesting a block in endocytosis from the basal membrane ([@bib155]). This work suggests that AFF-1 mediates scission of basal membrane endosomes and facilitates polarized apical exocytosis to elongate seamless tubes. These results uncover a novel and exciting function for the exoplasmic fusogen AFF-1 in endocytic fission and seamless tube elongation by membrane scission. It is conceivable that other exoplasmic fusogens such as syncytins, HAP2, and Myomaker/Myomerger have similar endocytic and tube elongation functions in placenta, gametes, and muscles, respectively.

EFF-1 has another unexpected role in a novel engulfment pathway clearing the distal process of the *C. elegans* tail spike cell (TSC) and the CEM sex-specific neuron. Mutants in *eff-1* fail to clear the distal TSC segment, and this phenotype can be rescued by expressing EFF-1 in the epidermal hyp10 cell ([@bib49]). This clearance pathway is independent of the classic engulfment pathways that eliminate the soma through CED-5/DOCK180 and CED-1. Thus, EFF-1 acts as a fission-inducing component necessary for sealing of the phagosome containing the distal process of the TSC. In *eff-1* mutants, the phagosome containing the distal process is unsealed, as evidenced by FRAP of muscle-secreted GFP surrounding the distal segment, proving continuity of extracellular GFP into the phagosome area. Moreover, EFF-1 localizes to the phagosome arm tips at the putative sealing region ([@bib49]). Previous investigations have proposed that the fission machinery responsible for endocytic and phagocytic scission acts from the endoplasmic (cytoplasmic) domain of the cellular membranes in eukaryotes. However, EFF-1 mediates sealing of the phagosome by a scission-inducing activity from the exoplasmic domain of the plasma membrane ([Fig. 2](#fig2){ref-type="fig"}). This surprising discovery may solve the mystery of the identity of the fission machinery that seals the phagosome. This mechanism for sealing of phagosomes may even have evolutionary implications in the origin of eukaryotes.

Concluding remarks {#s20}
==================

Fusion of plasma membranes is an essential and dynamic stage in fertilization and organ development, and in pathological processes like viral infections, cancer, and neuronal injury (Videos 1, 2, 3, 4, and 5). The identification of fusogens requires a complex analysis, and we suggest a scoring system based on the gold standards suggested above ([Table 1](#tbl1){ref-type="table"}). Ongoing work on identification of proteins that mediate cell fusion has to consider that in this multistep pathway fusion-initiation and fusion-completion may be performed by different proteins, neither of which can mediate fusion on its own. Moreover, each of the fusion stages can depend on the concerted activity of several proteins ([Fig. 1](#fig1){ref-type="fig"}). The identity of fusogens involved in gamete fusion in vertebrates, nematodes, and fungi is still missing, and even characterized cell fusion mechanisms are still not completely elucidated ([Table 2](#tbl2){ref-type="table"}). Cell--cell fusogens also function in diverse and unexpected cellular processes such as endocytic scission, sealing of phagosomes, auto-fusion during tube formation, remodeling of injured neurons, and fusion of extracellular vesicles to cells ([Fig. 2](#fig2){ref-type="fig"}). These recently discovered functions of eukaryotic fusogens promise to reveal universal mechanisms essential to every aspect of life. In the last decade it has become widely accepted that while many proteins control different aspects of cell fusion, only the fusogens are both necessary and sufficient to merge cells together. Recent structural data indicate eukaryotic fusogens have striking structural and functional similarities with better-characterized intracellular and viral fusogens, which opens exciting avenues for new candidate discoveries. Another crucial aspect involves the transcriptional, translational, and posttranslational regulation of the cell fusion process. In addition, membrane lipid composition, intracellular trafficking, and the cytoskeleton alter the activity, localization, and expression of fusogens so that they fuse the right cells at the right place and time.

As discussed above, some mechanistic motifs, including fusion dependence on actin-enriched protrusions, PS, AnxA5, and dynamin, are apparently shared by several different cell fusion processes, suggesting that some of the regulatory mechanisms can be conserved. Future research will determine how fusogens fuse cells, how cellular machineries regulate their activity, and the identity of yet unidentified fusogens.

Online supplemental material {#s21}
============================

Video 1 shows sperm--oocyte fusion in *C. elegans*. Video 2 shows myoblast fusion in *Drosophila* embryos. Video 3 shows mouse-derived macrophage-cancer cell fusion in vitro. Video 4 shows syncytia formation in the dorsal epidermis in *C. elegans* embryos. Video 5 shows axonal fusion: neuronal repair mechanism.
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